<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Med Rep</journal-id><journal-id journal-id-type="iso-abbrev">Mol Med Rep</journal-id><journal-title-group><journal-title>Molecular Medicine Reports</journal-title></journal-title-group><issn pub-type="ppub">1791-2997</issn><issn pub-type="epub">1791-3004</issn><publisher><publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26134272</article-id><article-id pub-id-type="pmc">4581829</article-id><article-id pub-id-type="doi">10.3892/mmr.2015.4021</article-id><article-id pub-id-type="publisher-id">mmr-12-04-4939</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Ischemic preconditioning maintains the immunoreactivities of glucokinase and glucokinase regulatory protein in neurons of the gerbil hippocampal CA1 region following transient cerebral ischemia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>CHO</surname><given-names>YOUNG SHIN</given-names></name><xref ref-type="aff" rid="af1-mmr-12-04-4939">1</xref><xref ref-type="aff" rid="af1-mmr-12-04-4939">2</xref><xref rid="fn1-mmr-12-04-4939" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>CHO</surname><given-names>JUN HWI</given-names></name><xref ref-type="aff" rid="af1-mmr-12-04-4939">1</xref><xref rid="fn1-mmr-12-04-4939" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>SHIN</surname><given-names>BICH-NA</given-names></name><xref ref-type="aff" rid="af3-mmr-12-04-4939">3</xref></contrib><contrib contrib-type="author"><name><surname>CHO</surname><given-names>GEUM-SIL</given-names></name><xref ref-type="aff" rid="af4-mmr-12-04-4939">4</xref></contrib><contrib contrib-type="author"><name><surname>KIM</surname><given-names>IN HYE</given-names></name><xref ref-type="aff" rid="af5-mmr-12-04-4939">5</xref></contrib><contrib contrib-type="author"><name><surname>PARK</surname><given-names>JOON HA</given-names></name><xref ref-type="aff" rid="af5-mmr-12-04-4939">5</xref></contrib><contrib contrib-type="author"><name><surname>AHN</surname><given-names>JI HYEON</given-names></name><xref ref-type="aff" rid="af5-mmr-12-04-4939">5</xref></contrib><contrib contrib-type="author"><name><surname>OHK</surname><given-names>TAEK GEUN</given-names></name><xref ref-type="aff" rid="af1-mmr-12-04-4939">1</xref><xref ref-type="aff" rid="af6-mmr-12-04-4939">6</xref></contrib><contrib contrib-type="author"><name><surname>CHO</surname><given-names>BYUNG-RYUL</given-names></name><xref ref-type="aff" rid="af7-mmr-12-04-4939">7</xref></contrib><contrib contrib-type="author"><name><surname>KIM</surname><given-names>YOUNG-MYEONG</given-names></name><xref ref-type="aff" rid="af8-mmr-12-04-4939">8</xref></contrib><contrib contrib-type="author"><name><surname>HONG</surname><given-names>SEONGKWEON</given-names></name><xref ref-type="aff" rid="af9-mmr-12-04-4939">9</xref></contrib><contrib contrib-type="author"><name><surname>WON</surname><given-names>MOO-HO</given-names></name><xref ref-type="aff" rid="af5-mmr-12-04-4939">5</xref><xref ref-type="corresp" rid="c1-mmr-12-04-4939"/></contrib><contrib contrib-type="author"><name><surname>LEE</surname><given-names>JAE-CHUL</given-names></name><xref ref-type="aff" rid="af5-mmr-12-04-4939">5</xref><xref ref-type="corresp" rid="c1-mmr-12-04-4939"/></contrib></contrib-group><aff id="af1-mmr-12-04-4939"><label>1</label>Department of Emergency Medicine, School of Medicine, Kangwon National University, Chuncheon, Gangwon 200-701</aff><aff id="af2-mmr-12-04-4939"><label>2</label>Department of Emergency Medicine, Seoul Hospital, College of Medicine, Sooncheonhyang University, Seoul 140-743</aff><aff id="af3-mmr-12-04-4939"><label>3</label>Department of Physiology, College of Medicine and Institute of Neurodegeneration and Neuroregeneration, Hallym University, Chuncheon, Gangwon 200-702</aff><aff id="af4-mmr-12-04-4939"><label>4</label>Department of Neuroscience, College of Medicine, Korea University, Seoul 136-705</aff><aff id="af5-mmr-12-04-4939"><label>5</label>Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, Gangwon 200-701</aff><aff id="af6-mmr-12-04-4939"><label>6</label>Department of Emergency Medicine, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul 150-950</aff><aff id="af7-mmr-12-04-4939"><label>7</label>Departments of Internal Medicine, Kangwon National University, Chuncheon, Gangwon 200-701, Republic of Korea</aff><aff id="af8-mmr-12-04-4939"><label>8</label>Molecular and Cellular Biochemistry, Kangwon National University, Chuncheon, Gangwon 200-701, Republic of Korea</aff><aff id="af9-mmr-12-04-4939"><label>9</label>Surgery, School of Medicine, Kangwon National University, Chuncheon, Gangwon 200-701, Republic of Korea</aff><author-notes><corresp id="c1-mmr-12-04-4939">Correspondence to: Professor Moo-Ho Won, or Dr Jae-Chul Lee, Department of Neurobiology, School of Medicine, Kangwon National University, 1 Kangwondaehak Street, Chuncheon, Gangwon 200-701, Republic of Korea, E-mail: <email>mhwon@kangwon.ac.kr</email>, E-mail: <email>anajclee@kangwon.ac.kr</email></corresp><fn id="fn1-mmr-12-04-4939"><label>*</label><p>Contributed equally</p></fn></author-notes><pub-date pub-type="ppub"><month>10</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>02</day><month>7</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>02</day><month>7</month><year>2015</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>12</volume><issue>4</issue><fpage>4939</fpage><lpage>4946</lpage><history><date date-type="received"><day>24</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>15</day><month>6</month><year>2015</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Cho.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0"><license-p>This is an open access article distributed under the terms of a Creative Commons Attribution License</license-p></license></permissions><abstract><p>Glucokinase (GK) is involved in the control of blood glucose homeostasis. In the present study, the effect of ischemic preconditioning (IPC) on the immunoreactivities of GK and its regulatory protein (GKRP) following 5 min of transient cerebral ischemia was investigated in gerbils. The gerbils were randomly assigned to four groups (sham-operated group, ischemia-operated group, IPC + sham-operated group and IPC + ischemia-operated group). IPC was induced by subjecting the gerbils to 2 min of ischemia, followed by 1 day of recovery. In the ischemia-operated group, a significant loss of neurons was observed in the stratum pyramidale (SP) of the hippocampal CA1 region (CA1) at 5 days post-ischemia; however, in the IPC+ischemia-operated group, the neurons in the SP were well protected. Following immunohistochemical investigation, the immunoreactivities of GK and GKRP in the neurons of the SP were markedly decreased in the CA1, but not the CA2/3, from 2 days post-ischemia, and were almost undetectable in the SP 5 days post-ischemia. In the IPC + ischemia-operated group, the immunoreactivities of GK and GKRP in the SP of the CA1 were similar to those in the sham-group. In brief, the findings of the present study demonstrated that IPC notably maintained the immunoreactivities of GK and GKRP in the neurons of the SP of CA1 following ischemia-reperfusion. This indicated that GK and GKRP may be necessary for neuron survival against transient cerebral ischemia.</p></abstract><kwd-group><kwd>ischemic preconditioning</kwd><kwd>ischemia-reperfusion</kwd><kwd>delayed neuronal death</kwd><kwd>glucokinase</kwd><kwd>glucokinase regulatory protein</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Brain ischemia results in the deprivation of oxygen and glucose in brain tissue, which may lead to permanent brain damage. Several clinical conditions can give rise to global cerebral ischemia; a frequent cause is cardiac arrest, which is a significant worldwide health problem (<xref rid="b1-mmr-12-04-4939" ref-type="bibr">1</xref>&#x02013;<xref rid="b3-mmr-12-04-4939" ref-type="bibr">3</xref>). Mongolian gerbils are widely used as an animal model of chronic or transient cerebral ischemia, as ~90% of the gerbils lack the communicating vessels between the carotid and vertebral arteries (<xref rid="b4-mmr-12-04-4939" ref-type="bibr">4</xref>). An important feature of cerebral ischemic damage is the vulnerability of specific neuronal populations. In particular, pyramidal neurons in the hippocampal CA1 region do not die immediately but survive for several days, which is referred to as 'delayed neuronal death' (<xref rid="b5-mmr-12-04-4939" ref-type="bibr">5</xref>). It is well known that the delayed neuronal death is associated with multiple mechanisms, including changes in energy metabolism, oxidative stress, neurotoxicity and neuroinflammation (<xref rid="b6-mmr-12-04-4939" ref-type="bibr">6</xref>&#x02013;<xref rid="b9-mmr-12-04-4939" ref-type="bibr">9</xref>). However, the exact mechanisms underlying neuronal damage in ischemia and delayed neuronal death remain to be fully elucidated.</p><p>Ischemic preconditioning (IPC) represents an important adaptation of the central nervous system to sub-lethal ischemia, which results in an increased tolerance to ischemia in the central nervous system to a subsequent longer or lethal period of ischemia (<xref rid="b10-mmr-12-04-4939" ref-type="bibr">10</xref>,<xref rid="b11-mmr-12-04-4939" ref-type="bibr">11</xref>). IPC induces the expression of a diverse family of genes involved in cytoprotection, which, in turn, encode proteins that enhance brain resistance to ischemia (<xref rid="b12-mmr-12-04-4939" ref-type="bibr">12</xref>). This mechanism has been termed 'ischemic tolerance,' and the basic mechanisms underlying ischemic tolerance remain to be fully elucidated (<xref rid="b13-mmr-12-04-4939" ref-type="bibr">13</xref>).</p><p>Glucokinase (GK), a member of the hexokinase family, catalyzes the ATP-dependent phosphorylation of glucose to produce glucose-6-phosphate. GK is expressed predominantly in the liver, pancreatic &#x003b2;-cells and brain (<xref rid="b14-mmr-12-04-4939" ref-type="bibr">14</xref>&#x02013;<xref rid="b17-mmr-12-04-4939" ref-type="bibr">17</xref>), and its activity is generally modulated by glucokinase regulatory protein (GKRP), which is stimulated by binding fructose-6-phosphate and suppressed by binding fructose-1-phosphate (<xref rid="b18-mmr-12-04-4939" ref-type="bibr">18</xref>&#x02013;<xref rid="b20-mmr-12-04-4939" ref-type="bibr">20</xref>). GK and GKRP are important in the regulation of glucose homeostasis, as glucose sensors involved in the control of food intake (<xref rid="b18-mmr-12-04-4939" ref-type="bibr">18</xref>,<xref rid="b21-mmr-12-04-4939" ref-type="bibr">21</xref>). Certain studies have suggested an association between neuronal cell death and glucose dysregulation (<xref rid="b22-mmr-12-04-4939" ref-type="bibr">22</xref>,<xref rid="b23-mmr-12-04-4939" ref-type="bibr">23</xref>). In addition, our previous study reported that changes in the expression of GK and GKRP, which are expressed in the hippocampus, were associated with neuronal loss (<xref rid="b24-mmr-12-04-4939" ref-type="bibr">24</xref>). However, the expression patterns of GK and GKRP in the brain of IPC-mediated animals following transient cerebral ischemia remain to be fully elucidated.</p><p>Therefore, the present study was performed to examine whether GK and GKRP are associated with IPC-induced neuroprotection, which has been widely accepted by a number of previous studies (<xref rid="b11-mmr-12-04-4939" ref-type="bibr">11</xref>,<xref rid="b12-mmr-12-04-4939" ref-type="bibr">12</xref>), following transient cerebral ischemia in the hippocampus of the gerbil, which is considered a suitable animal model of transient cerebral ischemia (<xref rid="b25-mmr-12-04-4939" ref-type="bibr">25</xref>,<xref rid="b26-mmr-12-04-4939" ref-type="bibr">26</xref>).</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Experimental animals</title><p>The present study used male Mongolian gerbils (<italic>Meriones unguiculatus</italic>), obtained from the Experimental Animal Center, Kangwon National University (Chuncheon, South Korea). The gerbils used were 6 months of age (body weight, 65&#x02013;75 g). The animals were housed in a conventional state under suitable temperature (23&#x000b0;C) and humidity (60%) control, with a 12-h light/12-h dark cycle, and were provided with free access to food and water. All experimental protocols were approved by the Institutional Animal Care and Use Committee at Kangwon University (approval no. KW-130424-1) and adhered to guidelines that are in compliance with the current international laws and policies (Guide for the Care and Use of Laboratory Animals). All the experiments were performed in a manner to minimize the number of animals used and the suffering caused by the procedures used in the present study.</p></sec><sec><title>Induction of transient cerebral ischemia in animal groups</title><p>The animals were divided into four groups: i) sham-operated group (sham group; n=7 at each time point), in which the bilateral common carotid arteries were exposed, but no ischemia was induced (sham-surgery) in the animals; ii) ischemia-operated group (ischemia group; n=7 at each time-point), in which the animals were exposed to 5 min of transient ischemia; iii) IPC + sham-operated group (IPC + sham group; n=7 at each time-point), in which the animals were subjected to a 2 min sublethal ischemic insult prior to sham surgery; and iv) IPC + ischemia-operated group (IPC + ischemia group; n=7 at each time-point), in which the animals were subjected to a 2 min sublethal ischemic insult prior to 5 min of transient ischemia. The preconditioning paradigm has been previously confirmed to be effective at protecting neurons against ischemia in this ischemic model (<xref rid="b27-mmr-12-04-4939" ref-type="bibr">27</xref>). The animals in the ischemia group and the IPC + ischemia groups were assigned recovery durations of 1, 2 and 5 days, as pyramidal neurons in the hippocampal CA1 region do not die until 3 days and begin to die 4 days after ischemia-reperfusion (<xref rid="b5-mmr-12-04-4939" ref-type="bibr">5</xref>).</p><p>Transient cerebral ischemia was developed according to our previously described method (<xref rid="b9-mmr-12-04-4939" ref-type="bibr">9</xref>). The experimental animals were anesthetized using a mixture of 2.5% isoflurane (Baxter, Deerfield, IL, USA) in 33% oxygen and 67% nitrous oxide (Chil-Seung Gas Co., Gyeonggi-do, Korea). Under an operating microscope (Boom Stand Zoom trinocular microscope, Shanghai Optical Instrument Factory, Shanghai, China), a ventral neck incision was made and the bilateral common carotid arteries were gently exposed. Ischemia was induced by occluding the arteries using non-traumatic aneurysm clips (Yasargil FE 723 K; Aesculap, Tuttlingen, Germany). The complete interruption of blood flow was confirmed by observing the central artery in the retinae using an ophthalmoscope (HEINE K180<sup>&#x000ae;</sup>; Heine Optotechnik, Herrsching, Germany). Following occlusion for 2 or 5 min, the aneurysm clips were removed from the common carotid arteries. The body (rectal) temperature under free-regulating or normothermic (37&#x000b1;0.5&#x000b0;C) conditions was monitored using a rectal temperature probe (TR-100; Fine Science Tools, Foster City, CA) and maintained using a thermometric blanket prior to, during and following surgery, until the animals had completely recovered from anesthesia. Subsequently, the animals were maintained on the thermal incubator (temperature, 23&#x000b0;C; humidity, 60%; Mirae Medical Industry, Seoul, South Korea) to maintain the body temperature of animals until the animals were sacrificed.</p></sec><sec><title>Tissue processing for histology</title><p>All the animals were anesthetized with pentobarbital sodium and perfused transcardially with 0.1 M phosphate-buffered saline (PBS; pH 7.4) followed by 4% paraformaldehyde (Samchun Pure Chemical Co., Ltd., Gyeonggi-do, Korea) in 0.1 M phosphate-buffer (PB; pH 7.4). The brains were removed and post-fixed in the same fixative for 6 h. The brain tissues were cryoprotected by infiltration with 30% sucrose overnight. The frozen tissues were then serially sectioned on a cryostat (CM1900 UV; Leica, Wetzlar, Germany) into 30 <italic>&#x000b5;</italic>m coronal sections, and were collected into six-well plates containing PBS.</p></sec><sec><title>Cresyl violet (CV) staining</title><p>The levels of neuronal death in the hippocampal CA1 region in each group were examined using CV staining. The sections were mounted on gelatin-coated microscope slides. Cresyl violet acetate (Sigma-Aldrich, St. Louis, MO) was dissolved at 1.0% (w/v) in distilled water, and glacial acetic acid (Marienfeld-Superior, Lauda-K&#x000f6;nigshofen, Germany) was added to this solution. The sections were stained and dehydrated by immersion in serial ethanol baths, and were then mounted using Canada balsam (Kanto Chemical, Co., Inc., Tokyo, Japan).</p></sec><sec><title>Neuronal nuclei (NeuN) immunohistochemistry</title><p>To examine the neuronal changes in the hippocampal CA1 region following transient cerebral ischemia using anti-NeuN, a marker for neurons, the sections were sequentially treated with 0.3% hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) in PBS for 30 min and 10% normal goat serum in 0.05 M PBS for 30 min. The sections were then incubated with diluted mouse anti-NeuN, a neuron-specific soluble nuclear antigen, (1:1,000; Chemicon International, Temecula, CA) overnight at at 4&#x000b0;C. Subsequently, the tissues were exposed to biotinylated horse anti-mouse IgG and streptavidin peroxidase complex (Vector Laboratories, Inc., Burlingame, CA). The sections were then visualized by staining with 0.05% 3,3&#x02032;-diaminobenzidine in 0.1 M Tris-HCl buffer and mounted on the gelatin-coated slides. Following dehydration, the sections were mounted using Canada balsam (Kanto Chemical, Co., Inc.).</p></sec><sec><title>Fluoro-Jade B (F-J B) histofluorescence</title><p>To examine neuronal death in the CA1 region at each time-point following ischemia, F-J B, a high affinity fluorescent marker for the localization of neuronal degeneration, histofluorescence was performed (<xref rid="b28-mmr-12-04-4939" ref-type="bibr">28</xref>). The sections were first immersed in a solution containing 1% sodium hydroxide in 80% alcohol, followed by immersion in 70% alcohol. The sections were then transferred into a solution of 0.06% potassium permanganate, followed by transfer to a 0.0004% F-J B (Histochem, Jefferson, AR, USA) staining solution. Following washing with PBS three times, the sections were placed on a slide warmer at ~50&#x000b0;C, and then examined using an epifluorescent microscope (LSM510 META NLO; Carl Zeiss, G&#x000f6;ttingen, Germany) with blue (450&#x02013;490 nm) excitation light and a barrier filter. Using this method, neurons that undergo degeneration fluoresce brightly, compared with the background (<xref rid="b10-mmr-12-04-4939" ref-type="bibr">10</xref>).</p></sec><sec><title>Cell counts</title><p>All measurements were performed in a blinded-manner, to ensure objectivity, by three observers for each experiment, with measurements of experimental samples under the same conditions. According to anatomical landmarks corresponding to AP, between &#x02212;1.4 and &#x02212;1.9 mm of the gerbil brain atlas, the tissue sections were selected with a 300-<italic>&#x000b5;</italic>m interval, and cell counts were obtained by averaging the total numbers of cells in 15 sections from each animal in each group. The numbers of NeuN- and F-J B-positive cells were counted in a 200&#x000d7;200 <italic>&#x000b5;</italic>m square, which was centred approximately at the center of the CA1 region using an image analyzing system (Optimas 6.5; CyberMetrics, Scottsdale, AZ, USA). The cell counts were obtained by averaging the total number from each animal per group.</p></sec><sec><title>Immunohistochemistry for GK and GKRP</title><p>To obtain accurate data for immunoreactivity, the sections from the sham-operated, IPC + sham, ischemia-operated and IPC + ischemia groups (n=7 at each time-point) were stained, according to the above-mentioned NeuN immunohistochemical staining. The sections were incubated with diluted rabbit anti-GK (1:200; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) and goat anti-GKRP (1:200; Santa Cruz Biotechnology, Inc.), followed by incubation with and subsequently biotinylated horse anti-rabbit or anti-goat IgG and streptavidin peroxidase complex (1:200; Vector Laboratories, Inc.). In order to establish the specificity of the immunostaining, a negative control was included, in which pre-immune serum was used in place of the primary antibody. The negative control resulted in the absence of immunoreactivity in any structures.</p><p>A total of 20 sections per animal were selected to quantitatively analyze the immunoreactivities of GK and GKRP. The cellular immunoreactivities of GK and GKRP were graded in the hippocampal CA1 region. Digital images of the CA1 region, including the strata oriens, pyramidale and radiatum in the hippocampus proper, were captured using an AxioM1 light microscope (Carl Zeiss) equipped with a digital camera (MRc5; Axiocam, Carl Zeiss) connected to a PC monitor. Semi-quantification of the intensity of GK+ and GKRP+ structures were evaluated using digital image analysis software (MetaMorph 4.01; Universal Imaging Corp.). The level of immunoreactivity was scaled as &#x02212;, &#x000b1;, + or ++, representing no staining (gray scale value, &#x02265;200), weakly positive staining (gray scale value, 150&#x02013;199), moderate staining (gray scale value, 100&#x02013;149), or marked staining (gray scale value, &#x02264;99) (<xref rid="b29-mmr-12-04-4939" ref-type="bibr">29</xref>).</p></sec><sec><title>Statistical analysis</title><p>All data are presented as the mean &#x000b1; standard error of the mean. A multiple-sample comparison was performed to compared the differences between groups, using analysis of variance. Tukey's multiple range test was used as a post-hoc test, using the criterion of the least significant differences. SAS version 9.2 (SAS Institute Inc., Cary, NC, USA) was used to perform the analyses. P&#x0003c;0.05 was considered to indicate a statistically significant difference.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Determination of neuronal damage using cresyl violet-positive (CV<sup>+</sup>) cells</title><p>The present study examined whether IPC was associated with an increase in neuronal survival in the hippocampal CA1 region following ischemia. In the sham group, the CV<sup>+</sup> cells were readily observed in all subregions of the hippocampus (<xref rid="f1-mmr-12-04-4939" ref-type="fig">Fig. 1A and B</xref>). Neurons in the stratum pyramidale (SP) were relatively large and pyramid-like or round in shape. In the IPC + sham group, the CA1 pyramidal cells were well stained with CV (<xref rid="f1-mmr-12-04-4939" ref-type="fig">Fig. 1C and D</xref>). At 5 days post-ischemia-reperfusion, the number of CV<sup>+</sup> cells in the sham group was significantly decreased in the SP of the CA1 region, but not the CA2/3 region, compared with those of the ischemia group (<xref rid="f1-mmr-12-04-4939" ref-type="fig">Fig. 1E</xref>). The damaged cells were shrunken and contained dark and polygonal nuclei (<xref rid="f1-mmr-12-04-4939" ref-type="fig">Fig. 1F</xref>).</p><p>In the IPC + ischemia group, the distribution pattern of CV<sup>+</sup> cells in the SP was similar to that observed in the IPC + sham group 5 days after ischemia-reperfusion (<xref rid="f1-mmr-12-04-4939" ref-type="fig">Fig. 1G and H</xref>).</p></sec><sec><title>NeuN<sup>+</sup> and F-J B<sup>+</sup> neurons</title><p>The protection afforded by IPC in the CA1 region was assessed using NeuN immunohisto-chemistry and F-J B histofluorescence staining (<xref rid="f2-mmr-12-04-4939" ref-type="fig">Fig. 2</xref>). In the sham group, the CA1 pyramidal neurons were well-stained with NeuN (<xref rid="tI-mmr-12-04-4939" ref-type="table">Table I</xref>; <xref rid="f2-mmr-12-04-4939" ref-type="fig">Fig. 2A</xref>); however, no F-J B<sup>+</sup> neurons were identified (<xref rid="tI-mmr-12-04-4939" ref-type="table">Table I</xref>; <xref rid="f2-mmr-12-04-4939" ref-type="fig">Fig. 2B</xref>). In the IPC + sham group, pyramidal neurons in the CA1 region were also well-stained with NeuN (<xref rid="f2-mmr-12-04-4939" ref-type="fig">Fig. 2C</xref>), and no F-J B<sup>+</sup> cells were observed (<xref rid="tI-mmr-12-04-4939" ref-type="table">Table I</xref>; <xref rid="f2-mmr-12-04-4939" ref-type="fig">Fig. 2C and D</xref>).</p><p>At 5 days post-ischemia, the number of NeuN<sup>+</sup> neurons were markedly decreased in the SP of the CA1 region (<xref rid="tI-mmr-12-04-4939" ref-type="table">Table I</xref>; <xref rid="f2-mmr-12-04-4939" ref-type="fig">Fig. 2E</xref>) and several F-J B<sup>+</sup> cells were detected in the SP of the CA1 region (<xref rid="tI-mmr-12-04-4939" ref-type="table">Table I</xref>, <xref rid="f2-mmr-12-04-4939" ref-type="fig">Fig. 2F</xref>).</p><p>In the IPC + ischemia group, no significant difference was observed in the distribution patterns of the NeuN<sup>+</sup> and F-J B<sup>+</sup> neurons in the SP 5 day after ischemia-reperfusion, compared with those in the IPC + sham group (<xref rid="tI-mmr-12-04-4939" ref-type="table">Table I</xref>; <xref rid="f2-mmr-12-04-4939" ref-type="fig">Fig. 2G and H</xref>).</p></sec><sec><title>GK immunoreactivity</title><p>In the sham group, marked GK immunoreactivity was detected in neurons of the SP of the CA1-3 regions (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f3-mmr-12-04-4939" ref-type="fig">Fig. 3A</xref>). In the ischemia group, GK immunoreactivity was altered in the CA1 region, but not in the CA2/3 region. At 1 day-post ischemia-reperfusion, GK immunoreactivity in the SP was not significantly different, compared with that in the sham group (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f3-mmr-12-04-4939" ref-type="fig">Fig. 3B</xref>). However, GK immunoreactivity in the SP was distinctively decreased 2 days after ischemia-reperfusion (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f3-mmr-12-04-4939" ref-type="fig">Fig. 3C</xref>). At 5 days-post ischemia-reperfusion, GK immunoreactivity was almost undetected in the pyramidal neurons of the SP (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f3-mmr-12-04-4939" ref-type="fig">Fig. 3D</xref>). However, in the CA2/3 region, no significant changes in GK immunoreactivity were observed following ischemia-reperfusion (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>).</p><p>In the IPC + sham group, marked GK immunoreactivity was readily detected in the SP of the CA1-3 regions (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f3-mmr-12-04-4939" ref-type="fig">Fig. 3E</xref>). In the IPC + ischemia-group, GK immunoreactivity in the SP of the CA1-3 regions was well-maintained following ischemia-reperfusion (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f3-mmr-12-04-4939" ref-type="fig">Fig. 3F&#x02013;H</xref>).</p></sec><sec><title>GKRP immunoreactivity</title><p>In the sham group, marked GKRP immunoreactivity was detected, predominantly in the SP of the CA1-3 regions. In this group, moderate GKRP immunoreactivity was observed in cells of the strata oriens and radiatum (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f4-mmr-12-04-4939" ref-type="fig">Fig. 4A</xref>). In the ischemia groups, GKRP immunoreactivity was altered in the CA1 region, but notin the CA2/3 region. At 1 day post-ischemia-reperfusion, no change in GKRP immunoreactivity was observed in the SP of the CA1 region, compared with that in the sham group (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f4-mmr-12-04-4939" ref-type="fig">Fig. 4B</xref>). However, GKRP immunoreactivity in the SP was marginally decreased 2 days after ischemia-reperfusion (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f4-mmr-12-04-4939" ref-type="fig">Fig. 4C</xref>). At 5 days post-ischemia-reperfusion, GKRP immunoreactivity was notably decreased in the SP of the CA1 region; however, at this time-point, marked GKRP immunoreactivity was observed in several non-pyramidal cells in the strata oriens and radiatum (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f4-mmr-12-04-4939" ref-type="fig">Fig. 4D</xref>). In the CA2/3 region, no significant changes were identified in GKRP immunoreactivity following ischemia-reperfusion (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>).</p><p>In the IPC + sham group, marked GKRP immunoreactivity in the CA1-3 regions was well-detected in the neurons of the SP, and moderate GKRP immunoreactivity was observed in the cells of the strata oriens and radiatum (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f4-mmr-12-04-4939" ref-type="fig">Fig. 4E</xref>). In the IPC + ischemia group, no significant changes in GKRP immunoreactivity were observed in the CA1-3 regions following ischemia-reperfusion (<xref rid="tII-mmr-12-04-4939" ref-type="table">Table II</xref>; <xref rid="f4-mmr-12-04-4939" ref-type="fig">Fig. 4F&#x02013;H</xref>).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>GK is important in the control of blood glucose homeostasis. In the present study, the effect of IPC on the immunoreactivities of GK and its regulatory protein GKRP were examined, following 5 min of transient cerebral ischemia in gerbils. The gerbils were randomly assigned into a sham-operated group, ischemia-operated group, IPC + sham-operated group and IPC + ischemia-operated group. IPC was induced by subjecting the gerbils to 2 min of ischemia followed by 1 day of recovery. In the immunohistochemical investigation, the immunoreactivities of the GK and GKRP in neurons of the SP were distinctively decreased in the CA1, but not the CA2/3, from 2 days post-ischemia, and weer almost undetectable in the SP 5 days post-ischemia. In the IPC + ischemia-operated group, the immunoreactivities of GK and GKRP in the SP of the CA1 were similar to those in the sham group. Therefore, these findings demonstrated that IPC maintains immunoreactivities of GK and GKRP in neurons of the SP of the CA1 following ischemia-reperfusion, and indicated that GK and GKRP may be necessary for neuronal survival against transient cerebral ischemia.</p><p>The concept of IPC is defined as a brief, non-injurious episode of ischemia, which can protect the brain cells from a subsequent longer ischemic insult (<xref rid="b10-mmr-12-04-4939" ref-type="bibr">10</xref>,<xref rid="b11-mmr-12-04-4939" ref-type="bibr">11</xref>). The first description of IPC in the brain was reported in a study by Kitagawa <italic>et al</italic> (<xref rid="b30-mmr-12-04-4939" ref-type="bibr">30</xref>) in a gerbil model of global ischemia. Further studies have been performed in other animal models, including global and focal cerebral ischemia (<xref rid="b12-mmr-12-04-4939" ref-type="bibr">12</xref>,<xref rid="b31-mmr-12-04-4939" ref-type="bibr">31</xref>&#x02013;<xref rid="b35-mmr-12-04-4939" ref-type="bibr">35</xref>). The preconditioning time-period used in the present study was determined by that described in a previous report (<xref rid="b27-mmr-12-04-4939" ref-type="bibr">27</xref>), which indicated that at least a 1 day interval between the sublethal 2 min ischemia and lethal 5 min ischemia is necessary for induction of the neuroprotection of the CA1 pyramidal cells. This protective mechanism has been termed 'ischemic tolerance,', however, the molecular mechanisms underlying ischemic tolerance remain to be fully elucidated. In the present study, a significantly protective effect of IPC against delayed neuronal death was observed in the hippocampal CA1 region following 5 min of transient cerebral ischemia in gerbils. At 5 days post-ischemic insult, pyramidal neurons in the CA1 region, but not the CA2/3, region exhibited features of neuronal death, and significant reductions in the numbers of CV<sup>+</sup> and NeuN<sup>+</sup> neurons and the appearance of F-J B<sup>+</sup> neurons were observed.</p><p>In the present study, the endogenous expression levels of GK and GKRP in the CA1 region were compared between the ischemia group and the IPC + ischemia group and found that the immunoreactivities of GK and GKRP were well-detected in the pyramidal neurons of the CA1-3 regions, although the immunoreactivities were significantly decreased in the ischemic CA1 region following ischemia-reperfusion. Therefore, it is likely that GK and GKRP in the pyramidal neurons, which are the principal cells of the hippocampus, may be important in glucose metabolism. This finding is supported by a previous study that reported that the immunoreactivity of glucagon-like peptide-1 receptor (GLP-1R) is decreased in the gerbil hippocampal CA1 region 2 days after ischemia-reperfusion (<xref rid="b36-mmr-12-04-4939" ref-type="bibr">36</xref>). It has also been observed that GLP-1R stimulation with exendin-4 leads to a protective effect against ischemic damage in the hippocampal CA1 region following transient cerebral ischemia (<xref rid="b36-mmr-12-04-4939" ref-type="bibr">36</xref>). On the basis of the previous and present findings, it is likely that the ischemia-induced alteration of glucose metabolism may be associated with delayed neuronal death in the hippocampal CA1 region following transient cerebral ischemia. In addition, the maintained GK and GKRP immunoreactivities following IPC in the present study reflected potential survival mechanisms of the CA1 pyramidal neurons following transient ischemic injury.</p><p>Cerebral ischemia leads to the alteration of energy metabolism in the brain (<xref rid="b37-mmr-12-04-4939" ref-type="bibr">37</xref>). It is well known that transient cerebral ischemia induces the modification of glucose metabolism in the hippocampal CA1 region, and it is associated with the development of neuronal cell damage and death (<xref rid="b38-mmr-12-04-4939" ref-type="bibr">38</xref>). As neurons require a constant supply of glucose for normal function, glucose is a major source of energy metabolism for the central nervous system (<xref rid="b39-mmr-12-04-4939" ref-type="bibr">39</xref>). Several studies have documented the effect of glucose-sensing neuropeptides on the development of post-ischemic glucose dysfunction and neuronal damage (<xref rid="b22-mmr-12-04-4939" ref-type="bibr">22</xref>,<xref rid="b23-mmr-12-04-4939" ref-type="bibr">23</xref>), and evidence from a previous <italic>in vitro</italic> study revealed that glucose itself promotes the development of caspase-dependent apoptosis during reoxygenation following oxygen and glucose deprivation, and promotes the production of reactive oxygen species, including superoxide anion, hydrogen peroxide and peroxynitrite (<xref rid="b40-mmr-12-04-4939" ref-type="bibr">40</xref>). GK and GKRP have important regulatory roles in glucose metabolism as a glucose sensor. Alvarez <italic>et al</italic> (<xref rid="b18-mmr-12-04-4939" ref-type="bibr">18</xref>) reported that the presence of GK interactions with GKRP in the rat hypothalamus may be involved in glucose sensing process and metabolic regulation. It has also been reported that GK modulates the activity of ATP-sensitive K+ channels and determines the rate of cell firing (<xref rid="b41-mmr-12-04-4939" ref-type="bibr">41</xref>). In addition, Mies <italic>et al</italic> (<xref rid="b42-mmr-12-04-4939" ref-type="bibr">42</xref>) demonstrated that ATP levels in the CA1 region are unchanged between 6 h and 2 days post-ischemia, but reduce to ~70% 4 days post-ischemia. Therefore, GK can control glycolysis and may be a major candidate as a regulator of ATP production and K<sub>ATP</sub> channel activity (<xref rid="b41-mmr-12-04-4939" ref-type="bibr">41</xref>).</p><p>In conclusion, the present study demonstrated that IPC maintained the immunoreactivities of GK and GKRP in the CA1 pyramidal neurons following 5 min of transient ischemia, and that CA1 pyramidal neurons death did not occur following ischemia-reperfusion. These results suggested that GK and GKRP may be involved in protecting neurons from ischemia-reperfusion injury and that maintained GK and GKRP expression by IPC in the ischemic CA1 region may be a fundamental mechanism for survival of neurons after transient cerebral ischemia.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank Mr. Seung Uk Lee for their technical assistance. This work was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea, funded by the Ministry of Science, ICT and future Planning (grant. no. NRF-2014R1A2A2A0100 5307) and by the NRF of Korea, funded by the Ministry of Education, Science and Technology (grant. no. 2010-0010580).</p></ack><ref-list><title>References</title><ref id="b1-mmr-12-04-4939"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neigh</surname><given-names>GN</given-names></name><name><surname>Glasper</surname><given-names>ER</given-names></name><name><surname>Kofler</surname><given-names>J</given-names></name><name><surname>Traystman</surname><given-names>RJ</given-names></name><name><surname>Mervis</surname><given-names>RF</given-names></name><name><surname>Bachstetter</surname><given-names>A</given-names></name><name><surname>DeVries</surname><given-names>AC</given-names></name></person-group><article-title>Cardiac arrest with cardiopulmonary resuscitation reduces dendritic spine density in CA1 pyramidal cells and selectively alters acquisition of spatial memory</article-title><source>Eur J Neurosci</source><volume>20</volume><fpage>1865</fpage><lpage>1872</lpage><year>2004</year><pub-id pub-id-type="doi">10.1111/j.1460-9568.2004.03649.x</pub-id><pub-id pub-id-type="pmid">15380008</pub-id></element-citation></ref><ref id="b2-mmr-12-04-4939"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>B&#x000f6;ttiger</surname><given-names>BW</given-names></name><name><surname>Popp</surname><given-names>E</given-names></name></person-group><article-title>Cerebral resuscitation after cardiocirculatory arrest</article-title><source>Anesth Analg</source><volume>108</volume><fpage>971</fpage><lpage>979</lpage><year>2009</year><pub-id pub-id-type="doi">10.1213/ane.0b013e318193ca99</pub-id><pub-id pub-id-type="pmid">19224811</pub-id></element-citation></ref><ref id="b3-mmr-12-04-4939"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harukuni</surname><given-names>I</given-names></name><name><surname>Bhardwaj</surname><given-names>A</given-names></name></person-group><article-title>Mechanisms of brain injury after global cerebral ischemia</article-title><source>Neurol Clin</source><volume>24</volume><fpage>1</fpage><lpage>21</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.ncl.2005.10.004</pub-id><pub-id pub-id-type="pmid">16443127</pub-id></element-citation></ref><ref id="b4-mmr-12-04-4939"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirino</surname><given-names>T</given-names></name><name><surname>Sano</surname><given-names>K</given-names></name></person-group><article-title>Selective vulnerability in the gerbil hippo-campus following transient ischemia</article-title><source>Acta Neuropathol</source><volume>62</volume><fpage>201</fpage><lpage>208</lpage><year>1984</year><pub-id pub-id-type="doi">10.1007/BF00691853</pub-id><pub-id pub-id-type="pmid">6695554</pub-id></element-citation></ref><ref id="b5-mmr-12-04-4939"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirino</surname><given-names>T</given-names></name></person-group><article-title>Delayed neuronal death in the gerbil hippocampus following ischemia</article-title><source>Brain Res</source><volume>239</volume><fpage>57</fpage><lpage>69</lpage><year>1982</year><pub-id pub-id-type="doi">10.1016/0006-8993(82)90833-2</pub-id><pub-id pub-id-type="pmid">7093691</pub-id></element-citation></ref><ref id="b6-mmr-12-04-4939"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>PH</given-names></name></person-group><article-title>Reactive oxygen radicals in signaling and damage in the ischemic brain</article-title><source>J Cereb Blood Flow Metab</source><volume>21</volume><fpage>2</fpage><lpage>14</lpage><year>2001</year><pub-id pub-id-type="doi">10.1097/00004647-200101000-00002</pub-id><pub-id pub-id-type="pmid">11149664</pub-id></element-citation></ref><ref id="b7-mmr-12-04-4939"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Won</surname><given-names>MH</given-names></name><name><surname>Kang</surname><given-names>TC</given-names></name><name><surname>Jeon</surname><given-names>GS</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name><name><surname>Kim</surname><given-names>DY</given-names></name><name><surname>Choi</surname><given-names>EM</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Choi</surname><given-names>CD</given-names></name><name><surname>Chung</surname><given-names>MH</given-names></name><name><surname>Cho</surname><given-names>SS</given-names></name></person-group><article-title>Immunohistochemical detection of oxidative DNA damage induced by ischemia-reperfusion insults in gerbil hippocampus in vivo</article-title><source>Brain Res</source><volume>836</volume><fpage>70</fpage><lpage>78</lpage><year>1999</year><pub-id pub-id-type="doi">10.1016/S0006-8993(99)01611-X</pub-id><pub-id pub-id-type="pmid">10415406</pub-id></element-citation></ref><ref id="b8-mmr-12-04-4939"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Won</surname><given-names>MH</given-names></name><name><surname>Kang</surname><given-names>T</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Jeon</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Seo</surname><given-names>JH</given-names></name><name><surname>Choi</surname><given-names>E</given-names></name><name><surname>Chung</surname><given-names>M</given-names></name><name><surname>Cho</surname><given-names>SS</given-names></name></person-group><article-title>The alterations of N-Methyl-D-aspartate receptor expressions and oxidative DNA damage in the CA1 area at the early time after ischemia-reperfusion insult</article-title><source>Neurosci Lett</source><volume>301</volume><fpage>139</fpage><lpage>142</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S0304-3940(01)01625-1</pub-id><pub-id pub-id-type="pmid">11248442</pub-id></element-citation></ref><ref id="b9-mmr-12-04-4939"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Yoo</surname><given-names>KY</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Hwang</surname><given-names>IK</given-names></name><name><surname>Ryu</surname><given-names>PD</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Kwon</surname><given-names>YG</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><name><surname>Won</surname><given-names>MH</given-names></name></person-group><article-title>Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress</article-title><source>Exp Neurol</source><volume>229</volume><fpage>450</fpage><lpage>459</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.expneurol.2011.03.015</pub-id><pub-id pub-id-type="pmid">21458451</pub-id></element-citation></ref><ref id="b10-mmr-12-04-4939"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmued</surname><given-names>LC</given-names></name><name><surname>Hopkins</surname><given-names>KJ</given-names></name></person-group><article-title>Fluoro-Jade B: A high affinity fluorescent marker for the localization of neuronal degeneration</article-title><source>Brain Res</source><volume>874</volume><fpage>123</fpage><lpage>130</lpage><year>2000</year><pub-id pub-id-type="doi">10.1016/S0006-8993(00)02513-0</pub-id><pub-id pub-id-type="pmid">10960596</pub-id></element-citation></ref><ref id="b11-mmr-12-04-4939"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehotsk&#x000fd;</surname><given-names>J</given-names></name><name><surname>Burda</surname><given-names>J</given-names></name><name><surname>Danielisov&#x000e1;</surname><given-names>V</given-names></name><name><surname>Gottlieb</surname><given-names>M</given-names></name><name><surname>Kaplan</surname><given-names>P</given-names></name><name><surname>Saniov&#x000e1;</surname><given-names>B</given-names></name></person-group><article-title>Ischemic tolerance: The mechanisms of neuroprotective strategy</article-title><source>Anatomical Rec (Hoboken)</source><volume>292</volume><fpage>2002</fpage><lpage>2012</lpage><year>2009</year><pub-id pub-id-type="doi">10.1002/ar.20970</pub-id></element-citation></ref><ref id="b12-mmr-12-04-4939"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gidday</surname><given-names>JM</given-names></name></person-group><article-title>Cerebral preconditioning and ischaemic tolerance</article-title><source>Nat Rev Neurosci</source><volume>7</volume><fpage>437</fpage><lpage>448</lpage><year>2006</year><pub-id pub-id-type="doi">10.1038/nrn1927</pub-id><pub-id pub-id-type="pmid">16715053</pub-id></element-citation></ref><ref id="b13-mmr-12-04-4939"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kardesoglu</surname><given-names>E</given-names></name><name><surname>Isilak</surname><given-names>Z</given-names></name><name><surname>Uz</surname><given-names>O</given-names></name><name><surname>Yiginer</surname><given-names>O</given-names></name></person-group><article-title>Ischemic conditioning: A current concept in reducing reperfusion injury</article-title><source>Chin Med J (Engl)</source><volume>124</volume><fpage>480</fpage><year>2011</year><pub-id pub-id-type="pmid">21362357</pub-id></element-citation></ref><ref id="b14-mmr-12-04-4939"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Jetton</surname><given-names>TL</given-names></name><name><surname>Zimmerman</surname><given-names>EC</given-names></name><name><surname>Najafi</surname><given-names>H</given-names></name><name><surname>Matschinsky</surname><given-names>FM</given-names></name><name><surname>Magnuson</surname><given-names>MA</given-names></name></person-group><article-title>Effects of alternate RNA splicing on glucokinase isoform activities in the pancreatic islet, liver and pituitary</article-title><source>J Biol Chem</source><volume>266</volume><fpage>6999</fpage><lpage>7007</lpage><year>1991</year><pub-id pub-id-type="pmid">2016311</pub-id></element-citation></ref><ref id="b15-mmr-12-04-4939"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maekawa</surname><given-names>F</given-names></name><name><surname>Toyoda</surname><given-names>Y</given-names></name><name><surname>Torii</surname><given-names>N</given-names></name><name><surname>Miwa</surname><given-names>I</given-names></name><name><surname>Thompson</surname><given-names>RC</given-names></name><name><surname>Foster</surname><given-names>DL</given-names></name><name><surname>Tsukahara</surname><given-names>S</given-names></name><name><surname>Tsukamura</surname><given-names>H</given-names></name><name><surname>Maeda</surname><given-names>K</given-names></name></person-group><article-title>Localization of glucokinase-like immunoreactivity in the rat lower brain stem: For possible location of brain glucose-sensing mechanisms</article-title><source>Endocrinology</source><volume>141</volume><fpage>375</fpage><lpage>384</lpage><year>2000</year><pub-id pub-id-type="pmid">10614660</pub-id></element-citation></ref><ref id="b16-mmr-12-04-4939"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roncero</surname><given-names>I</given-names></name><name><surname>Sanz</surname><given-names>C</given-names></name><name><surname>Alvarez</surname><given-names>E</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>P</given-names></name><name><surname>Barrio</surname><given-names>PA</given-names></name><name><surname>Bl&#x000e1;zquez</surname><given-names>E</given-names></name></person-group><article-title>Glucokinase and glucokinase regulatory proteins are functionally coexpressed before birth in the rat brain</article-title><source>J Neuroendocrinol</source><volume>21</volume><fpage>973</fpage><lpage>981</lpage><year>2009</year><pub-id pub-id-type="doi">10.1111/j.1365-2826.2009.01919.x</pub-id><pub-id pub-id-type="pmid">19807849</pub-id></element-citation></ref><ref id="b17-mmr-12-04-4939"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roncero</surname><given-names>I</given-names></name><name><surname>Alvarez</surname><given-names>E</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>P</given-names></name><name><surname>Bl&#x000e1;zquez</surname><given-names>E</given-names></name></person-group><article-title>Functional glucokinase isoforms are expressed in rat brain</article-title><source>J Neurochem</source><volume>74</volume><fpage>1848</fpage><lpage>1857</lpage><year>2000</year><pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.0741848.x</pub-id><pub-id pub-id-type="pmid">10800927</pub-id></element-citation></ref><ref id="b18-mmr-12-04-4939"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>E</given-names></name><name><surname>Roncero</surname><given-names>I</given-names></name><name><surname>Chowen</surname><given-names>JA</given-names></name><name><surname>V&#x000e1;zquez</surname><given-names>P</given-names></name><name><surname>Bl&#x000e1;zquez</surname><given-names>E</given-names></name></person-group><article-title>Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain</article-title><source>J Neurochem</source><volume>80</volume><fpage>45</fpage><lpage>53</lpage><year>2002</year><pub-id pub-id-type="doi">10.1046/j.0022-3042.2001.00677.x</pub-id><pub-id pub-id-type="pmid">11796742</pub-id></element-citation></ref><ref id="b19-mmr-12-04-4939"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malaisse</surname><given-names>WJ</given-names></name><name><surname>Malaisse-Lagae</surname><given-names>F</given-names></name><name><surname>Davies</surname><given-names>DR</given-names></name><name><surname>Vandercammen</surname><given-names>A</given-names></name><name><surname>Van Schaftingen</surname><given-names>E</given-names></name></person-group><article-title>Regulation of glucokinase by a fructose-1-phosphate-sensitive protein in pancreatic islets</article-title><source>Eur J Biochem</source><volume>190</volume><fpage>539</fpage><lpage>545</lpage><year>1990</year><pub-id pub-id-type="doi">10.1111/j.1432-1033.1990.tb15607.x</pub-id><pub-id pub-id-type="pmid">2197090</pub-id></element-citation></ref><ref id="b20-mmr-12-04-4939"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Schaftingen</surname><given-names>E</given-names></name></person-group><article-title>Short-term regulation of glucokinase</article-title><source>Diabetologia</source><volume>37</volume><issue>Suppl 2</issue><fpage>S43</fpage><lpage>S47</lpage><year>1994</year><pub-id pub-id-type="doi">10.1007/BF00400825</pub-id><pub-id pub-id-type="pmid">7821739</pub-id></element-citation></ref><ref id="b21-mmr-12-04-4939"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandercammen</surname><given-names>A</given-names></name><name><surname>Van Schaftingen</surname><given-names>E</given-names></name></person-group><article-title>The mechanism by which rat liver glucokinase is inhibited by the regulatory protein</article-title><source>Eur J Biochem</source><volume>191</volume><fpage>483</fpage><lpage>489</lpage><year>1990</year><pub-id pub-id-type="doi">10.1111/j.1432-1033.1990.tb19147.x</pub-id><pub-id pub-id-type="pmid">2384095</pub-id></element-citation></ref><ref id="b22-mmr-12-04-4939"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname><given-names>S</given-names></name><name><surname>Fujita-Hamabe</surname><given-names>W</given-names></name><name><surname>Tokuyama</surname><given-names>S</given-names></name></person-group><article-title>Ischemic stroke and glucose intolerance: A review of the evidence and exploration of novel therapeutic targets</article-title><source>J Pharmacol Sci</source><volume>118</volume><fpage>1</fpage><lpage>13</lpage><year>2012</year><pub-id pub-id-type="doi">10.1254/jphs.11R04CR</pub-id><pub-id pub-id-type="pmid">22188858</pub-id></element-citation></ref><ref id="b23-mmr-12-04-4939"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YY</given-names></name><name><surname>Lin</surname><given-names>SY</given-names></name><name><surname>Chuang</surname><given-names>YH</given-names></name><name><surname>Chen</surname><given-names>CJ</given-names></name><name><surname>Tung</surname><given-names>KC</given-names></name><name><surname>Sheu</surname><given-names>WH</given-names></name></person-group><article-title>Adipose proinflammatory cytokine expression through sympathetic system is associated with hyperglycemia and insulin resistance in a rat ischemic stroke model</article-title><source>Am J Physiol Endocrinol Metab</source><volume>300</volume><fpage>E155</fpage><lpage>E163</lpage><year>2011</year><pub-id pub-id-type="doi">10.1152/ajpendo.00301.2010</pub-id><pub-id pub-id-type="pmid">20978230</pub-id></element-citation></ref><ref id="b24-mmr-12-04-4939"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Kim</surname><given-names>IH</given-names></name><name><surname>Ahn</surname><given-names>JH</given-names></name><name><surname>Cho</surname><given-names>JH</given-names></name><name><surname>Yan</surname><given-names>BC</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name><name><surname>Lee</surname><given-names>TH</given-names></name><name><surname>Seo</surname><given-names>JY</given-names></name><name><surname>Cho</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Time-course changes in immunoreactivities of glucokinase and glucokinase regulatory protein in the gerbil hippocampus following transient cerebral ischemia</article-title><source>Neurochem Res</source><volume>38</volume><fpage>2640</fpage><lpage>2649</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/s11064-013-1182-1</pub-id><pub-id pub-id-type="pmid">24146201</pub-id></element-citation></ref><ref id="b25-mmr-12-04-4939"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YR</given-names></name><name><surname>Lei</surname><given-names>RY</given-names></name><name><surname>Wang</surname><given-names>CE</given-names></name><name><surname>Zhang</surname><given-names>BA</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>HC</given-names></name><name><surname>Zhang</surname><given-names>GB</given-names></name></person-group><article-title>Effects of catalpol on ATPase and amino acids in gerbils with cerebral ischemia/reperfusion injury</article-title><source>Neurol Sci</source><volume>35</volume><fpage>1229</fpage><lpage>1233</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s10072-014-1687-7</pub-id><pub-id pub-id-type="pmid">24584634</pub-id></element-citation></ref><ref id="b26-mmr-12-04-4939"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>QL</given-names></name><name><surname>Wang</surname><given-names>GZ</given-names></name><name><surname>Deng</surname><given-names>TZ</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>MH</given-names></name><name><surname>Wang</surname><given-names>SW</given-names></name></person-group><article-title>The protective roles of mitochondrial ATP-sensitive potassium channels during hypoxia-ischemia-reperfusion in brain</article-title><source>Neurosci Lett</source><volume>491</volume><fpage>63</fpage><lpage>67</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.neulet.2010.12.065</pub-id><pub-id pub-id-type="pmid">21215294</pub-id></element-citation></ref><ref id="b27-mmr-12-04-4939"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Katsumata</surname><given-names>T</given-names></name><name><surname>Nishiyama</surname><given-names>Y</given-names></name><name><surname>Otori</surname><given-names>T</given-names></name><name><surname>Katsura</surname><given-names>K</given-names></name><name><surname>Katayama</surname><given-names>Y</given-names></name></person-group><article-title>Effect of ischemic preconditioning on cerebral blood flow after subsequent lethal ischemia in gerbils</article-title><source>Life Sci</source><volume>78</volume><fpage>1713</fpage><lpage>1719</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.lfs.2005.08.008</pub-id><pub-id pub-id-type="pmid">16253278</pub-id></element-citation></ref><ref id="b28-mmr-12-04-4939"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Candelario-Jalil</surname><given-names>E</given-names></name><name><surname>Alvarez</surname><given-names>D</given-names></name><name><surname>Merino</surname><given-names>N</given-names></name><name><surname>Le&#x000f3;n</surname><given-names>OS</given-names></name></person-group><article-title>Delayed treatment with nimesulide reduces measures of oxidative stress following global ischemic brain injury in gerbils</article-title><source>Neurosci Res</source><volume>47</volume><fpage>245</fpage><lpage>253</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0168-0102(03)00184-6</pub-id><pub-id pub-id-type="pmid">14512150</pub-id></element-citation></ref><ref id="b29-mmr-12-04-4939"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Yoo</surname><given-names>KY</given-names></name><name><surname>Ryu</surname><given-names>PD</given-names></name><name><surname>Won</surname><given-names>MH</given-names></name></person-group><article-title>Heat shock protein 90 and its cochaperone, p23, are markedly increased in the aged gerbil hippocampus</article-title><source>Exp Gerontol</source><volume>46</volume><fpage>768</fpage><lpage>772</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.exger.2011.05.002</pub-id><pub-id pub-id-type="pmid">21601628</pub-id></element-citation></ref><ref id="b30-mmr-12-04-4939"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>K</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Kuwabara</surname><given-names>K</given-names></name><name><surname>Tagaya</surname><given-names>M</given-names></name><name><surname>Ohtsuki</surname><given-names>T</given-names></name><name><surname>Hata</surname><given-names>R</given-names></name><name><surname>Ueda</surname><given-names>H</given-names></name><name><surname>Handa</surname><given-names>N</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Kamada</surname><given-names>T</given-names></name></person-group><article-title>'Ischemic tolerance' phenomenon detected in various brain regions</article-title><source>Brain Res</source><volume>561</volume><fpage>203</fpage><lpage>211</lpage><year>1991</year><pub-id pub-id-type="doi">10.1016/0006-8993(91)91596-S</pub-id><pub-id pub-id-type="pmid">1802339</pub-id></element-citation></ref><ref id="b31-mmr-12-04-4939"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Nakata</surname><given-names>N</given-names></name><name><surname>Kogure</surname><given-names>K</given-names></name></person-group><article-title>Protection of rat hippo-campus against ischemic neuronal damage by pretreatment with sublethal ischemia</article-title><source>Brain Res</source><volume>586</volume><fpage>121</fpage><lpage>124</lpage><year>1992</year><pub-id pub-id-type="doi">10.1016/0006-8993(92)91380-W</pub-id><pub-id pub-id-type="pmid">1380876</pub-id></element-citation></ref><ref id="b32-mmr-12-04-4939"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirino</surname><given-names>T</given-names></name><name><surname>Tsujita</surname><given-names>Y</given-names></name><name><surname>Tamura</surname><given-names>A</given-names></name></person-group><article-title>Induced tolerance to ischemia in gerbil hippocampal neurons</article-title><source>J Cereb Blood Flow Metab</source><volume>11</volume><fpage>299</fpage><lpage>307</lpage><year>1991</year><pub-id pub-id-type="doi">10.1038/jcbfm.1991.62</pub-id><pub-id pub-id-type="pmid">1997501</pub-id></element-citation></ref><ref id="b33-mmr-12-04-4939"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishi</surname><given-names>S</given-names></name><name><surname>Taki</surname><given-names>W</given-names></name><name><surname>Uemura</surname><given-names>Y</given-names></name><name><surname>Higashi</surname><given-names>T</given-names></name><name><surname>Kikuchi</surname><given-names>H</given-names></name><name><surname>Kudoh</surname><given-names>H</given-names></name><name><surname>Satoh</surname><given-names>M</given-names></name><name><surname>Nagata</surname><given-names>K</given-names></name></person-group><article-title>Ischemic tolerance due to the induction of HSP70 in a rat ischemic recirculation model</article-title><source>Brain Res</source><volume>615</volume><fpage>281</fpage><lpage>288</lpage><year>1993</year><pub-id pub-id-type="doi">10.1016/0006-8993(93)90039-P</pub-id><pub-id pub-id-type="pmid">8364736</pub-id></element-citation></ref><ref id="b34-mmr-12-04-4939"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyoda</surname><given-names>T</given-names></name><name><surname>Kassell</surname><given-names>NF</given-names></name><name><surname>Lee</surname><given-names>KS</given-names></name></person-group><article-title>Induction of ischemic tolerance and antioxidant activity by brief focal ischemia</article-title><source>Neuroreport</source><volume>8</volume><fpage>847</fpage><lpage>851</lpage><year>1997</year><pub-id pub-id-type="doi">10.1097/00001756-199703030-00008</pub-id><pub-id pub-id-type="pmid">9141050</pub-id></element-citation></ref><ref id="b35-mmr-12-04-4939"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stagliano</surname><given-names>NE</given-names></name><name><surname>P&#x000e9;rez-Pinz&#x000f3;n</surname><given-names>MA</given-names></name><name><surname>Moskowitz</surname><given-names>MA</given-names></name><name><surname>Huang</surname><given-names>PL</given-names></name></person-group><article-title>Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice</article-title><source>J Cereb Blood Flow Metab</source><volume>19</volume><fpage>757</fpage><lpage>761</lpage><year>1999</year><pub-id pub-id-type="doi">10.1097/00004647-199907000-00005</pub-id><pub-id pub-id-type="pmid">10413030</pub-id></element-citation></ref><ref id="b36-mmr-12-04-4939"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Yan</surname><given-names>B</given-names></name><name><surname>Yoo</surname><given-names>KY</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Kwon</surname><given-names>SH</given-names></name><name><surname>Her</surname><given-names>S</given-names></name><name><surname>Sohn</surname><given-names>Y</given-names></name><name><surname>Hwang</surname><given-names>IK</given-names></name><name><surname>Cho</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><etal/></person-group><article-title>Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia</article-title><source>J Neurosci Res</source><volume>89</volume><fpage>1103</fpage><lpage>1113</lpage><year>2011</year><pub-id pub-id-type="doi">10.1002/jnr.22596</pub-id><pub-id pub-id-type="pmid">21472764</pub-id></element-citation></ref><ref id="b37-mmr-12-04-4939"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dirnagl</surname><given-names>U</given-names></name><name><surname>Iadecola</surname><given-names>C</given-names></name><name><surname>Moskowitz</surname><given-names>MA</given-names></name></person-group><article-title>Pathobiology of ischaemic stroke: An integrated view</article-title><source>Trends Neurosci</source><volume>22</volume><fpage>391</fpage><lpage>397</lpage><year>1999</year><pub-id pub-id-type="doi">10.1016/S0166-2236(99)01401-0</pub-id><pub-id pub-id-type="pmid">10441299</pub-id></element-citation></ref><ref id="b38-mmr-12-04-4939"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>MB</given-names></name><name><surname>Wright</surname><given-names>DC</given-names></name><name><surname>Diemer</surname><given-names>NH</given-names></name></person-group><article-title>Postischemic glucose metabolism is modified in the hippocampal CA1 region depleted of excitatory input or pyramidal cells</article-title><source>J Cereb Blood Flow Metab</source><volume>10</volume><fpage>243</fpage><lpage>251</lpage><year>1990</year><pub-id pub-id-type="doi">10.1038/jcbfm.1990.41</pub-id><pub-id pub-id-type="pmid">2303541</pub-id></element-citation></ref><ref id="b39-mmr-12-04-4939"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>BE</given-names></name></person-group><article-title>Glucosensing neurons do more than just sense glucose</article-title><source>Int J Obes Relat Metab Disord</source><volume>25</volume><issue>Suppl 5</issue><fpage>S68</fpage><lpage>S72</lpage><year>2001</year><pub-id pub-id-type="doi">10.1038/sj.ijo.0801916</pub-id><pub-id pub-id-type="pmid">11840219</pub-id></element-citation></ref><ref id="b40-mmr-12-04-4939"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra-Perez</surname><given-names>A</given-names></name><name><surname>Verdaguer</surname><given-names>E</given-names></name><name><surname>Planas</surname><given-names>AM</given-names></name><name><surname>Santalucia</surname><given-names>T</given-names></name></person-group><article-title>Glucose promotes caspase-dependent delayed cell death after a transient episode of oxygen and glucose deprivation in SH-SY5Y cells</article-title><source>J Neurochem</source><volume>106</volume><fpage>1237</fpage><lpage>1247</lpage><year>2008</year><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05467.x</pub-id><pub-id pub-id-type="pmid">18466326</pub-id></element-citation></ref><ref id="b41-mmr-12-04-4939"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn-Meynell</surname><given-names>AA</given-names></name><name><surname>Routh</surname><given-names>VH</given-names></name><name><surname>Kang</surname><given-names>L</given-names></name><name><surname>Gaspers</surname><given-names>L</given-names></name><name><surname>Levin</surname><given-names>BE</given-names></name></person-group><article-title>Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons</article-title><source>Diabetes</source><volume>51</volume><fpage>2056</fpage><lpage>2065</lpage><year>2002</year><pub-id pub-id-type="doi">10.2337/diabetes.51.7.2056</pub-id><pub-id pub-id-type="pmid">12086933</pub-id></element-citation></ref><ref id="b42-mmr-12-04-4939"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mies</surname><given-names>G</given-names></name><name><surname>Paschen</surname><given-names>W</given-names></name><name><surname>Hossmann</surname><given-names>KA</given-names></name></person-group><article-title>Cerebral blood flow, glucose utilization, regional glucose and ATP content during the maturation period of delayed ischemic injury in gerbil brain</article-title><source>J Cereb Blood Flow Metab</source><volume>10</volume><fpage>638</fpage><lpage>645</lpage><year>1990</year><pub-id pub-id-type="doi">10.1038/jcbfm.1990.116</pub-id><pub-id pub-id-type="pmid">2384537</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-mmr-12-04-4939" orientation="portrait" position="float"><label>Figure 1</label><caption><p>CV histochemical staining in the CA1 region of the ischemia (left two columns) and IPC + ischemia (right two columns) groups at (A&#x02013;D) sham and (E&#x02013;H) 5 days post-ischemia-reperfusion. In the ischemia group, few CV<sup>+</sup> cells (arrows) were observed in the SP 5 days post-ischemia, whereas CV<sup>+</sup> cells were abundant (white asterisk) in the SP of the IPC + ischemia group. Scale bar=800 <italic>&#x000b5;</italic>m. (A, C, E, G) and 50 <italic>&#x000b5;</italic>m. (B, D, F, H). CV, Cresyl violet; SP, stratum pyramidale; DG, dentate gyrus; SO, stratum oriens; SR, stratum radiatum.</p></caption><graphic xlink:href="MMR-12-04-4939-g00"/></fig><fig id="f2-mmr-12-04-4939" orientation="portrait" position="float"><label>Figure 2</label><caption><p>NeuN immunohistochemistry (the first and third columns) and F&#x02013;J B histofluorescence staining (the second and fourth columns) in the CA1 region of the ischemia group (left two columns) and IPC + ischemia group (right two columns) at (A&#x02013;D) sham and (E&#x02013;H) 5 days-post ischemia-reperfusion. In the sham group, several NeuN<sup>+</sup> neurons and no F&#x02013;J B<sup>+</sup> cells were detected in the SP. In the ischemia group, a few NeuN<sup>+</sup> neurons (black arrows) and several F&#x02013;J B<sup>+</sup> cells (white asterisks) were detected in the SP at 5 days post-ischemia. However, in the IPC + ischemia-group, abundant NeuN<sup>+</sup> neurons and no F&#x02013;J B<sup>+</sup> cells were detected in the SP at 5 days post-ischemia. Scale bar=50 <italic>&#x000b5;</italic>m. NeuN, neuronal nuclei; F&#x02013;J B, fluoro-Jade B; IPC, ischemic preconditioning; SP, stratum pyramidale; SO; stratum oriens, SR; stratum radiatum.</p></caption><graphic xlink:href="MMR-12-04-4939-g01"/></fig><fig id="f3-mmr-12-04-4939" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Immunohistochemistry to determine the expression of GK in the CA1 region of the (A&#x02013;D) ischemia and (E&#x02013;H) IPC + ischemia groups 1, 2 and 5 days following ischemia-reperfusion. GK immunoreactivity was readily detected in the SP in the sham group. GK immunoreactivity in the SP was decreased from 2 days post-ischemia, and GK immunoreactivity was markedly decreased (*) 5 days post-ischemia. However, in the IPC-operated sham- and IPC + ischemia-operated groups, GK immunoreactivity was markedly increased in the SP of CA1, and was maintained until 5 days post-ischemia. Scale bar=50 <italic>&#x000b5;</italic>m. GK, glucokinase; SP, stratum pyramidale; SO; stratum oriens, SR; stratum radiatum; IPC, ischemic preconditioning.</p></caption><graphic xlink:href="MMR-12-04-4939-g02"/></fig><fig id="f4-mmr-12-04-4939" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Immunohistochemistry for GKRP in the CA1 region of the (A&#x02013;D) ischemia and (E&#x02013;H) IPC + ischemia groups following sham surgery and 1, 2 and 5 days post-ischemia-reperfusion. GKRP immunoreactivity was readily detected in the SP in the sham-group. GKRP immunoreactivity in the SP was marginally decreased 2 days after ischemia-reperfusion. At 5 days post-ischemia, GKRP immunoreactivity was almost undetectable in the SP. At 5 days post- ischemia-reperfusion, marked GKRP immunoreactivity was observed in non-pyramidal cells (arrows) of the SO and SR. In the IPC + sham and IPC + ischemia groups, GKRP immunoreactivity was similar to that in the sham group. Scale Bar=50 <italic>&#x000b5;</italic>m. GKRP, glucokinase regulatory protein; IPC, ischemic preconditioning; SP, stratum pyramidale; SO; stratum oriens, SR; stratum radiatum.</p></caption><graphic xlink:href="MMR-12-04-4939-g03"/></fig><table-wrap id="tI-mmr-12-04-4939" orientation="portrait" position="float"><label>Table I</label><caption><p>Changes in the mean number of pyramidal neurons of the hippocampal CA1 region of gerbils in the ischemia and IPC + ischemia groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" rowspan="2" align="left" colspan="1">Time post-I-R (days)</th><th colspan="2" valign="bottom" align="center" rowspan="1">Ischemia-operated group
<hr/></th><th colspan="2" valign="bottom" align="center" rowspan="1">IPC + ischemia-operated group
<hr/></th></tr><tr><th valign="bottom" align="center" rowspan="1" colspan="1">NeuN<sup>+</sup></th><th valign="bottom" align="center" rowspan="1" colspan="1">F-J B<sup>+</sup></th><th valign="bottom" align="center" rowspan="1" colspan="1">NeuN<sup>+</sup></th><th valign="bottom" align="center" rowspan="1" colspan="1">F-J B<sup>+</sup></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Sham (no I-R)</td><td valign="top" align="center" rowspan="1" colspan="1">346&#x000b1;13.54</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">352&#x000b1;16.28</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">352&#x000b1;11.12</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="left" rowspan="1" colspan="1">349&#x000b1;18.36</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">349&#x000b1;12.98</td><td valign="top" align="center" rowspan="1" colspan="1">4&#x000b1;4.36<xref rid="tfn2-mmr-12-04-4939" ref-type="table-fn">a</xref></td><td valign="top" align="left" rowspan="1" colspan="1">355&#x000b1;17.34</td><td valign="top" align="center" rowspan="1" colspan="1">0</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000a0;&#x000a0;41&#x000b1;8.35<xref rid="tfn2-mmr-12-04-4939" ref-type="table-fn">a</xref>,<xref rid="tfn3-mmr-12-04-4939" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">134&#x000b1;17.69<xref rid="tfn2-mmr-12-04-4939" ref-type="table-fn">a</xref>,<xref rid="tfn3-mmr-12-04-4939" ref-type="table-fn">b</xref></td><td valign="top" align="left" rowspan="1" colspan="1">324&#x000b1;15.85<xref rid="tfn2-mmr-12-04-4939" ref-type="table-fn">a</xref>,<xref rid="tfn3-mmr-12-04-4939" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">24&#x000b1;5.54<xref rid="tfn2-mmr-12-04-4939" ref-type="table-fn">a</xref>,<xref rid="tfn3-mmr-12-04-4939" ref-type="table-fn">b</xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn1-mmr-12-04-4939"><p>Numbers of NeuN<sup>+</sup> and F-J B<sup>+</sup> cells were counted in a 200&#x000d7;200 <italic>&#x000b5;</italic>m square of the stratum pyramidale of the CA1 region following I-R (n=7 per group;</p></fn><fn id="tfn2-mmr-12-04-4939"><label>a</label><p>P&#x0003c;0.05, compared with the sham group;</p></fn><fn id="tfn3-mmr-12-04-4939"><label>b</label><p>P&#x0003c;0.05, compared with the 2 days). I-R, ischemia-reperfusion; IPC, ischemic preconditioning.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tII-mmr-12-04-4939" orientation="portrait" position="float"><label>Table II</label><caption><p>Semi-quantifications of the immunoreactivities of GK and GKRP in the hippocampal CA1 and CA2/3 regions in the ischemia and IPC + ischemia groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" rowspan="2" align="left" colspan="1">Antibody</th><th valign="bottom" rowspan="2" align="center" colspan="1">Region</th><th valign="bottom" rowspan="2" align="center" colspan="1">Group</th><th valign="bottom" rowspan="2" align="center" colspan="1">Category</th><th colspan="4" valign="bottom" align="center" rowspan="1">Time following ischemia-reperfusion
<hr/></th></tr><tr><th valign="bottom" align="center" rowspan="1" colspan="1">Sham</th><th valign="bottom" align="center" rowspan="1" colspan="1">1 day</th><th valign="bottom" align="center" rowspan="1" colspan="1">2 days</th><th valign="bottom" align="center" rowspan="1" colspan="1">5 days</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">GK</td><td valign="top" align="center" rowspan="1" colspan="1">CA1</td><td valign="top" align="left" rowspan="1" colspan="1">Ischemia</td><td valign="top" align="left" rowspan="1" colspan="1">CSP</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CSOR</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">IPC+ischemia</td><td valign="top" align="left" rowspan="1" colspan="1">CSP</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CSOR</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">CA2/3</td><td valign="top" align="left" rowspan="1" colspan="1">Ischemia</td><td valign="top" align="left" rowspan="1" colspan="1">CSP</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CSOR</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">IPC+ischemia</td><td valign="top" align="left" rowspan="1" colspan="1">CSP</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CSOR</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">GKRP</td><td valign="top" align="center" rowspan="1" colspan="1">CA1</td><td valign="top" align="left" rowspan="1" colspan="1">Ischemia</td><td valign="top" align="left" rowspan="1" colspan="1">CSP</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000b1;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CSOR</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">++</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">IPC+ischemia</td><td valign="top" align="left" rowspan="1" colspan="1">CSP</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CSOR</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">+</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">CA2/3</td><td valign="top" align="left" rowspan="1" colspan="1">Ischemia</td><td valign="top" align="left" rowspan="1" colspan="1">CSP</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CSOR</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">+</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">IPC+ischemia</td><td valign="top" align="left" rowspan="1" colspan="1">CSP</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td><td valign="top" align="center" rowspan="1" colspan="1">++</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">CSOR</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">+</td><td valign="top" align="center" rowspan="1" colspan="1">+</td></tr></tbody></table><table-wrap-foot><fn id="tfn4-mmr-12-04-4939"><p>Immunoreactivity is scaled as &#x02212;, &#x000b1;, + or ++, representing no staining, weakly positive staining, moderate staining, or marked staining, respectively. Sham, no ischemia reperfusion; CSP, cells in stratum pyramidale; CSOR, cells in stratum oriens and radiatum; IPC, ischemic preconditioning.</p></fn></table-wrap-foot></table-wrap></floats-group></article>